NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/30/2024
Back to search
Official data from USPTO
REVERSE IMMUNIZATION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
REVERSE IMMUNIZATION
ST13
US500000090818040Class
5
Filing
90818040
Registration
7295729
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
01/30/2024
Trademark type
Word
Nice classes
5
Filing date
07/08/2021
Registration date
01/30/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/30/2024
Last transaction
01/30/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Magadim, IL
Examiner
SINGER, MELANIE ALYSSA
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CANOPY IMMUNO-THERAPEUTICS LTD.
Representatives
Alexander Lazouski Lazouski IP LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Proteins being recombinant proteins in the nature of pharmaceutical preparations and substances for the treatment of autoimmuneallergic and inflammatory diseases and disorders; Proteins being recombinant proteins in the nature of pharmaceutical preparations and substances for the treatment of autoimmuneallergic and inflammatory diseases by eliminating specific lymphocytes lineages or modulating the immune response using a variety of recombinant proteins; Pharmaceutical preparations and substances for the treatment of autoimmuneallergic and inflammatory diseases and disorders by modulating the immune system by recombinant proteins that contain a targeting moiety and an effector moiety to eliminate specific lymphocytes lineages and attenuate or block the antibody creation and antigen specific immune response in autoimmuneAllergic and inflammatory diseases; Pharmaceutical preparations and substances for the treatment of autoimmuneallergic and inflammatory diseases and disorders by modulating the immune system by recombinant proteins that contain a targeting moiety and an effector moiety to eliminate specific lymphocytes lineages and attenuate or block the creation of the antibodies IgGIgE or IgA and antigen specific immune response in autoimmuneallergic and inflammatory diseases; Proteins including recombinant proteins pharmaceutical preparations and substances with potential immunomodulation activity to treat under and over responsiveness of the immune system
Publications
History of USPTO decisions and trademark events.
30 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
01/30/2024
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
12/28/2023
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
12/22/2023
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
07/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/25/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/25/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/25/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/23/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/23/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/23/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/23/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/23/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/23/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/23/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
05/14/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
05/14/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/15/2023
GNFR
FINAL REFUSAL E-MAILED
02/15/2023
CNFR
FINAL REFUSAL WRITTEN
02/15/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/15/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/15/2022
ALIE
ASSIGNED TO LIE
11/10/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/28/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/06/2022
GNRT
NON-FINAL ACTION E-MAILED
04/06/2022
CNRT
NON-FINAL ACTION WRITTEN
04/06/2022
DOCK
ASSIGNED TO EXAMINER
03/28/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/15/2021
NWAP
NEW APPLICATION ENTERED
07/12/2021
Continuous trademark protection
Get notified about every new filing that threatens REVERSE IMMUNIZATION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.